Guar Gum vs Sodium Aluminum Phosphate: which is worse?

What is Guar Gum?

Guar gum is a galactomannan polysaccharide extracted from guar beans (Cyamopsis tetragonoloba), grown primarily in India and Pakistan. It is a highly effective thickener — approximately 8 times more powerful than cornstarch — and functions as a dietary fiber. It is used extensively in food, pharmaceutical, and industrial applications.

What is Sodium Aluminum Phosphate?

Sodium aluminum phosphate (SALP) is a leavening acid and food additive used in baked goods, particularly self-rising flour and baking powder. It provides a slow, sustained leavening action during baking. SALP is also used as an emulsifying salt in processed cheese products.

Documented risks

Guar Gum: Generally recognized as safe. At high doses (e.g., dietary supplement doses of 10–20 g/day), guar gum can cause flatulence, bloating, and diarrhea. Historically, concentrated guar gum dietary supplements were associated with esophageal obstruction, prompting the FDA to ban such supplements in 1992. At typical food additive use levels, no significant safety concerns have been identified. EFSA confirmed its safety as a food additive in 2017.

Sodium Aluminum Phosphate: The primary health concern with SALP is aluminum exposure. Dietary aluminum intake has been studied in relation to neurotoxicity, and there is ongoing scientific debate about whether chronic dietary aluminum exposure contributes to Alzheimer's disease risk. EFSA's 2008 review of dietary aluminum exposure concluded that the tolerable weekly intake (TWI) was being exceeded by some European populations based on total dietary aluminum sources, raising concern. A 2011 EFSA risk assessment noted that certain high-aluminum sources (including baked goods from SALP-containing leavening agents) contributed meaningfully to total dietary aluminum. The WHO has set a PTWI (provisional tolerable weekly intake) of 2 mg/kg body weight/week for total aluminum. However, the causal link between dietary aluminum from food-grade SALP and Alzheimer's disease has not been definitively established in human studies.